WCLC 2019 - Barcelone

Retour sur le WCLC 2018 qui a eu lieu à Toronto (Canada).

Sélection IFCT du programme officiel (2 posters) : 

P1.01-66: Randomized Phase II Evaluating EGFR-TKI Associated with Anti-Estrogen in Women with Non-Squamous Advanced Stage NSCLC: IFCT-1003 LADIE Trial Julien Mazieres University Hospital, France
Abstract

P3.03-27: Somatic BRCA1/2 Mutations in Advanced NSCLC Patients: Description of a Sub-Population from the Ongoing Unicancer SAFIR02-Lung / IFCT-1301 Trial Jordi Remon Gustave Roussy Cancer Center, France
Abstract

Retour sur le WCLC 2017 qui a eu lieu à Yokohama (Japon)

Sélection IFCT du programme officiel (3 communications orales) :

OA 16.03 - Recurrences and 2<Sup>Nd</Sup> Primary Cancers in the IFCT-0302 Trial Assessing a CT-Scan-Based Follow-Up after Lung Cancer Surgery
Abstract

OA 17.05 - IFCT-1502 CLINIVO: Real-Life Experience with Nivolumab in 600 Patients (Pts) with Advanced Non-Small Cell Lung Cancer (NSCLC)
Abstract

OA 03.01 - Prevalence of Autoimmune Diseases in Thymic Epithelial Tumors (TET) Insights from RYTHMIC
Abstract

Lu 1893 fois Dernière modification le 03/10/2018